🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga

Published 17/05/2024, 20:04
© Reuters.  EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga
MSFT
-
LLY
-
ADBE
-
AAPL
-
AMZN
-
NVDA
-
GME
-
TSLA
-
META
-
NVO
-
AMC
-
GOOG
-
MEME
-

Benzinga - by Chris Katje, Benzinga Staff Writer.

The return of Roaring Kitty, aka Keith Gill, on social media increased interest in meme stocks and may have kickstarted a short rally to start the trading week.

While there are several ETFs that provide exposure to meme stocks, an ETF that previously focused exclusively on meme stocks closed in 2023. Benzinga chatted recently with the CEO of the company behind the MEME ETF.

What Happened: ETF company Roundhill Investments was the first to market with several thematic investment vehicles including a sports betting ETF, launched in 2020.

In December 2021, Roundhill launched a meme stock ETF aimed at capturing interest in meme stocks, which grew in popularity during the early months of the year.

The ETF, which had the appropriate MEME ticker, closed in November 2023. Roundhill Investments CEO Dave Mazza told Benzinga the ETF was closed "due to lack of assets under management and limited trading volume."

With meme stocks gaining interest once again, Benzinga reached out to find out what it would take to bring the ETF back.

"Time will tell is meme stocks make a meaningful comeback outside of the renewed interest in the last week. The current meme wave remains highly correlated in the original 2021 meme stocks, such as GME and AMC," Mazza said highlighting GameStop Corporation (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC).

Mazza said Roundhill had the MEME ticker around six months before launching the ETF and still has the ticker reserved today.

"We're always open to good ideas and welcome feedback on if a meme ETF would be a compelling offering to investors."

Mazza said Roundhill expected the current wave of interest in meme stocks will last a few weeks.

"Considering that AMC already announced plans to issue 23.3 million shares in a debt-for-equity swap, the hype may prove to be short-lived as they're increasing supply."

Mazza said that at Roundhill there was an internal debate on whether it was really Keith Gill posting on the Roaring Kitty X account.

"We believe it is indeed Keith Gill posting on X, but his end game may be different than just ‘liking the stock.'"

Related Link: EXCLUSIVE: Roundhill Launches Covered Call Bitcoin ETF, ‘Potential High Income From Bitcoin’s Volatility’

What's Next: While the MEME ETF was closed, other ETFs from Roundhill are thriving. Mazza highlighted the Roundhill Magnificent Seven ETF (NASDAQ:MAGS) and Roundhill Generative AI & Technology ETF (NYSE:CHAT).

"We recently crossed $1 billion in assets under management fueled by strong interest in our MAGS and CHAT ETFs. Our newer suite of options income ETFs hit $50 million as we continue to diversify our lineup," Mazza said.

The CHAT ETF has the following top holdings as plays on the growth of the AI sector:

NVIDIA Corp (NASDAQ:NVDA): 11.3%

Microsoft Corp (NASDAQ:MSFT): 10.4%

Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL): 5.3%

Meta Platforms Inc (NASDAQ:META): 4.2%

Adobe Inc (NASDAQ:ADBE): 3.7%

The Magnificent Seven ETF offers equal weight exposure, rebalanced quarterly, to the well-known stocks of Alphabet, Amazon.com Inc (NASDAQ:AMZN), Apple Inc (NASDAQ:AAPL), Meta Platforms, Microsoft, Nvidia and Tesla Inc (NASDAQ:TSLA).

Mazza also highlighted the Roundhill GLP-1 & Weight Loss ETF, which is coming soon with the ticker OZEM.

The new ETF will provide exposure to companies involved in the development of weight-loss drugs, according to the Roundhill website.

Weight loss drugs such as Ozempic and Wegovy from Novo Nordisk (NYSE:NVO) and Mounjaro from Eli Lilly and Company (NYSE:LLY) have taken the market by storm. Many other drug companies have weight loss drugs in the pipeline.

Shares of Novo Nordisk and Eli Lilly are up 57% and 77%, respectively, over the past year.

Read Next: EXCLUSIVE: Roundhill Launches Dividend Kings ETF With ‘The Gold Standard Of Dividend Growers,' Companies With ‘Incredible Resilience'

Photo: Tada Images via Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.